I’m curious of the medical minds on their interp
Post# of 148343
https://www.theguardian.com/science/2019/jun/...arly-death
My initial take is it may be positive for leronlimab as it may discourage or slow CAR-T treatments or approval that delete CCR5.......and I understand that with leronlimab it helps promote or activate the body’s own immune response (which is believed to be the cause of the early deaths for this small delta 32 population).